Track Record
Acquisition of Steripharma by Dislog Group
Fintrust Capital was honored to act as M&A advisor to the Dislog Group in its partial acquisition of Laboratoires Steripharma.
This strategic acquisition will enable Dislog Group to consolidate its Healthcare industrial division, in line with the Group's strategic vision of becoming a major industrial player focused on the life sciences economy.
Acquisition of Africare by Dislog Group
FinTrust Capital was honored to act as M&A advisor to Africare (specialized in the manufacture, import and distribution of consumable medical devices to healthcare institutions in Morocco) in the sale of 100% of its shares to Dislog Group.
This acquisition opens up new growth prospects for Africare and reinforces its commitment to quality, innovation and service to healthcare institutions. As for Dislog Group, this integration once again confirms its strong ambitions to consolidate its Healthcare division.
Acquisition of Botanic Pharma by Laprophan
FinTrust Capital is proud to have supported Botanic Pharma as their M&A advisor in forming a strategic partnership with Laprophan.
This acquisition will allow Botanic Pharma to benefit from the synergies with Laprophan, enhancing its position in the healthcare sector and boosting its capacity for innovation and product development. This move is part of Laprophan's growth strategy, which aims to deliver high-quality products and contribute to the advancement of the healthcare sector in Morocco.
Acquisition of Megaflex by Dislog Group
FinTrust Capital is proud to have supported Dislog Group as their M&A advisor in acquiring Megaflex, one of the national leaders in the distribution of in-vitro diagnostic products and equipment.
By integrating Megaflex into its operations, Dislog Group aims to solidify its presence and expand its healthcare value chain, reinforcing its role as a key player in the life sciences economy. For Megaflex, this acquisition marks the beginning of a new chapter of development under the leadership of Dislog Group.